Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1104, 234-239
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in OncologyClinical Pharmacology & Therapeutics, 2017
- Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samplesJournal of Pharmaceutical and Biomedical Analysis, 2017
- Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancerCancer Chemotherapy and Pharmacology, 2016
- The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma PatientsThe Journal of Clinical Pharmacology, 2016
- Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative studyAnalytica Chimica Acta, 2015
- Quantitative bioanalysis of paracetamol in rats using volumetric absorptive microsampling (VAMS)Journal of Pharmaceutical and Biomedical Analysis, 2015
- Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future DirectionsClinical Pharmacokinetics, 2014
- Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinomaCancer Chemotherapy and Pharmacology, 2014
- Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometryAnalytical and Bioanalytical Chemistry, 2012
- Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2009